Lexaria’s DehydraTECH™ technology is covered by issued and pending patents in over 40 countries around the world. Lexaria’s patent suite commenced with two initial 2014 US provisional patent application filings by the original Poppy’s Teas LLC inventors, which Lexaria acquired by way of exclusive, worldwide license rights and controlling interest in the founding company. Since then, Lexaria has broadened the patent suite considerably by refining the patent claims via further US provisional and utility patent filings and extending the breadth of the claims considerably to name many other beneficial compounds that the technology can be applied to and many other consumer product formats in which they can be formulated. Under US patent law, a patent upon issuance provides for 20 years of patent protection from the date of filing.
In addition to the US patent filings, Lexaria has also pursued international patent protection through filings under the Patent Cooperation Treaty, followed by national filings in 40+ jurisdictions of highest commercial potential thereunder.